Prof Therese Kinsella, founder and chief executive of Atxa Therapeutics. Photograph: Vincent Hoban

UCD spinout drug company Atxa Therapeutics, which is developing novel therapies that tackle a deadly heart condition, is seeking to raise $30 million (...)

New accounts filed by Forest Laboratories Holdings Ltd disclose the scale of the dividend payout across a number of payments in 2018. Photograph: Thomas White/Reuters

A Dublin-based subsidiary of the Irish-domiciled maker of Botox, Allergan, last year paid out dividends of $7 billion (€6.33 billion). New accounts f(...)

A company logo is seen at a Pfizer office in Dublin. Photograph: Cathal McNaughton/Reuters

US drug giant Pfizer has called off its planned $160 billion takeover of Dublin-based Allergan that would have led to its relocation to Ireland after(...)

A man walks past Pfizer’s world headquarters in New York. The group is reportedly holding talks with Allergan on a possible merger

Drug companies Pfizer and Allergan have confirmed that they were engaged in “friendly” talks about a possible megamerger which would make Ireland home(...)

Google said it is deeply committed to Ireland and will work to implement changes as they become law

As executives pore over the slow death of the “Double Irish” tax shelter favored by US companies, their reaction seems to be: don’t panic. The tax bre(...)

Modern, highly automated factories are already saturated with things that could be networked – sensors, controllers, switches, machines – but which, for the most part, aren’t. Photograph: Dado Galdieri/Bloomberg

The much-hyped and fast-developing “Internet of Things” (IoT), in which billions of devices and objects share data across the net, is already transfor(...)

Actavis’s acquisition of Forest Laboratories for approximately €  18 billion was one of the largest M&A deals in the first half of the year. Photograph:   Justin Sullivan/Getty Images

A flurry of high value M&A deals in the pharmaceutical sector has pushed the value of Irish deals to a record € 97.4 billion in the first six mont(...)

Ryanair repurchased 109,000 shares yesterday as part of its plans to return €1 billion in capital to shareholders by way of a combination of share buybacks and dividends.  Photograph: Rui Vieira/PA Wire

US stocks fluctuated, with the Standard & Poor’s 500 Index close to a record, as a $25 billion deal to acquire Forest Labo(...)

Forest Laboratories employs 320 people in Ireland. Dublin-headquartered Actavis, the world’s second-largest generic-drug maker by market value, is to buy Forest Labs for $25 billion. Photo: Jim Peppler

Actavis, the world’s second-largest generic-drug maker by market value, is to buy Forest Laboratories in a cash and stock deal valued at about(...)

Forest Laboratories: Brent Saunders, the new chief executive, said he would consider reversing the US pharma group in an Irish company in line with deals by other pharmaceutical companies. Photograph: Jim Peppler/Newsday

The new chief executive of Forest Laboratories would consider reversing the US pharma group in an Irish company in line with deals by other pharmac(...)

  • 1
  • 2
  • Next
  • Last »